| Year |
Citation |
Score |
| 2023 |
Gupta A, Carnazza M, Jones M, Darzynkiewicz Z, Halicka D, O'Connell T, Zhao H, Dadafarin S, Shin E, Schwarcz MD, Moscatello A, Tiwari RK, Geliebter J. Androgen Receptor Activation Induces Senescence in Thyroid Cancer Cells. Cancers. 15. PMID 37190127 DOI: 10.3390/cancers15082198 |
0.391 |
|
| 2022 |
Dadafarin S, Rodríguez TC, Carnazza MA, Tiwari RK, Moscatello A, Geliebter J. Expression Indicates Lymph Node Metastasis and Presence of Cancer-Associated Fibroblasts in Papillary Thyroid Cancer. Cells. 11. PMID 36231143 DOI: 10.3390/cells11193181 |
0.376 |
|
| 2021 |
Dadafarin S, Carnazza M, Islam HK, Moscatello A, Tiwari RK, Geliebter J. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis. Advances in Experimental Medicine and Biology. 1350: 145-155. PMID 34888848 DOI: 10.1007/978-3-030-83282-7_7 |
0.423 |
|
| 2021 |
Chakraborty S, Carnazza M, Jarboe T, DeSouza N, Li XM, Moscatello A, Geliebter J, Tiwari RK. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity. Advances in Experimental Medicine and Biology. 1350: 33-66. PMID 34888843 DOI: 10.1007/978-3-030-83282-7_2 |
0.33 |
|
| 2021 |
Jarboe T, Tuli NY, Chakraborty S, Maniyar RR, DeSouza N, Xiu-Min Li, Moscatello A, Geliebter J, Tiwari RK. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers. Advances in Experimental Medicine and Biology. 1350: 1-31. PMID 34888842 DOI: 10.1007/978-3-030-83282-7_1 |
0.421 |
|
| 2021 |
Jones ME, O'Connell TJ, Zhao H, Darzynkiewicz Z, Gupta A, Buchsbaum J, Shin E, Iacob C, Suslina N, Moscatello A, Schantz S, Tiwari R, Geliebter J. Androgen receptor activation decreases proliferation in thyroid cancer cells. Journal of Cellular Biochemistry. PMID 33876852 DOI: 10.1002/jcb.29934 |
0.444 |
|
| 2020 |
Reyes N, Bettin A, Geliebter J. Abstract 748: The small leucine-rich proteoglycan fibromodulin is a potential, novel serum and urinary biomarker for the detection of prostate cancer Clinical Trials. DOI: 10.1158/1538-7445.Am2020-748 |
0.413 |
|
| 2020 |
Reyes N, Tiwari R, Geliebter J. Abstract 5591: Differential profiles of pro-inflammatory chemokines identified in patients with prostate cancer and benign prostatic hyperplasia Immunology. 80: 5591-5591. DOI: 10.1158/1538-7445.Am2020-5591 |
0.441 |
|
| 2020 |
Dadafarin S, Carnazza MA, Moscatello A, Tiwari R, Geliebter J. Abstract 2236: Mechanism of androgen-mediated down-regulation of PD-L1 in thyroid cancer Immunology. 80: 2236-2236. DOI: 10.1158/1538-7445.Am2020-2236 |
0.462 |
|
| 2020 |
Chakraborty S, Jarboe T, Dadafarin S, Geliebter J, Moscatello A, Tiwari RK. Abstract 2235: Implications of HVEM/BTLA/LIGHT signaling in anaplastic thyroid cancer Immunology. DOI: 10.1158/1538-7445.Am2020-2235 |
0.428 |
|
| 2019 |
Maniyar R, Freund R, Malhotra A, Chakraborty S, Geliebter J, Wallack M, Tiwari RK. Abstract B174: Co-expression of stimulators and inhibitors of T-cell activation in melanoma Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B174 |
0.387 |
|
| 2019 |
Reyes N, Rebollo J, Tiwari R, Geliebter J. Abstract 520: Alteration of chemokine gene expression in PC-3 cells treated with NSAIDs Cancer Research. 79: 520-520. DOI: 10.1158/1538-7445.Sabcs18-520 |
0.484 |
|
| 2019 |
Dadafarin S, Gupta A, Dermigny K, Cavdar L, Pecchia B, Jones M, O'Connell T, Rasamny J, Suslina N, Iacob C, Schwarcz M, Kamat A, Budenz C, Berzofsky C, Jourdy D, ... ... Geliebter J, et al. Abstract 3570: Investigating coding and non-coding RNA in papillary thyroid cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3570 |
0.361 |
|
| 2019 |
Rahoma GB, Maniyar R, Chakraborty S, Singh S, Srinivasan A, Mittelman A, Geliebter J, Tiwari RK. Abstract 3562: Exosomes secreted by AC133+/CD34+cells harbor invasion potentiating miRNAs Cancer Research. 79: 3562-3562. DOI: 10.1158/1538-7445.Sabcs18-3562 |
0.349 |
|
| 2019 |
Chakraborty S, Maniyar RR, Dadafarin S, Rahoma GB, Singh S, Moscatello A, Geliebter J, Tiwari RK. Abstract 3237: Combinatorial immune checkpoint inhibitor therapy in anaplastic thyroid cancer Immunology. DOI: 10.1158/1538-7445.Sabcs18-3237 |
0.434 |
|
| 2019 |
Reyes N, Rebollo J, Geliebter J. Abstract 128: Effects of NSAIDs on gene expression of small leucine-rich proteoglycans in prostate cancer cells Cancer Research. 79: 128-128. DOI: 10.1158/1538-7445.Sabcs18-128 |
0.517 |
|
| 2019 |
Figueroa S, Tiwari R, Geliebter J, Reyes N. Abstract 4253: Differential expression of protein‐coding and non-coding RNAs in malignant melanoma Cancer Research. 79: 4253-4253. DOI: 10.1158/1538-7445.Am2019-4253 |
0.372 |
|
| 2019 |
Maniyar RR, Chakraborty S, Rahoma GB, Degliuomini JJ, Wallack M, Geliebter J, Tiwari RK. Abstract 3946: Tumor checkpoint inhibitor profiling for an optimal clinical response Cancer Research. 79: 3946-3946. DOI: 10.1158/1538-7445.Am2019-3946 |
0.363 |
|
| 2019 |
Jarboe T, Carnazza M, Chakraborty S, Yang N, Srivastava K, Geliebter J, Tiwari RK, Li X. Abstract 1863: Identification of anticancer agent from antiallergic treatment regimens of traditional Chinese medicine Cancer Research. 79: 1863-1863. DOI: 10.1158/1538-7445.Am2019-1863 |
0.474 |
|
| 2018 |
Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomarkers : Section a of Disease Markers. PMID 30614796 DOI: 10.3233/Cbm-181758 |
0.468 |
|
| 2018 |
Bednarczyk RB, Tuli NY, Hanly EK, Rahoma GB, Maniyar R, Mittelman A, Geliebter J, Tiwari RK. Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer. Oncotarget. 9: 24272-24282. PMID 29849939 DOI: 10.18632/Oncotarget.24917 |
0.367 |
|
| 2018 |
Iacobas DA, Tuli NY, Iacobas S, Rasamny JK, Moscatello A, Geliebter J, Tiwari RK. Gene master regulators of papillary and anaplastic thyroid cancers. Oncotarget. 9: 2410-2424. PMID 29416781 DOI: 10.18632/Oncotarget.23417 |
0.42 |
|
| 2018 |
Tiwari R, Rahoma GB, Tuli N, Bednarczyk R, Maniyar R, Chakraborty S, Singh S, Mittelman A, Geliebter J. Abstract P5-03-06: Novel targets of breast cancer associated with inflammatory tumor microenvironment Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P5-03-06 |
0.386 |
|
| 2018 |
Maniyar RR, Chakraborty S, Tuli NY, Rahoma GB, Singh S, Wallack M, Geliebter J, Tiwari RK. Abstract 714: A case for combining immunotherapy and targeted small molecule inhibitors: Immunoregulation by primary melanoma cells Cancer Research. 78: 714-714. DOI: 10.1158/1538-7445.Am2018-714 |
0.38 |
|
| 2018 |
Gupta A, Singh K, O'Connell TJ, Jones M, Rasamny J, Schwarcz M, Moscatello A, Shin E, Tiwari R, Geliebter J. Abstract 5750: Underlying inflammatory processes in non-neoplastic female thyroid serve as an immunological basis for the sex disparity in papillary thyroid cancer Cancer Research. 78: 5750-5750. DOI: 10.1158/1538-7445.Am2018-5750 |
0.499 |
|
| 2018 |
Reyes N, Benedetti I, Geliebter J. Abstract 5072: Immunohistochemical expression of CC-chemokine receptor-like 2/CCRL2 in a prostate cancer tissue microarray Tumor Biology. DOI: 10.1158/1538-7445.Am2018-5072 |
0.453 |
|
| 2018 |
Chakraborty S, Maniyar RR, Tuli NY, Rahoma GB, Singh S, Kamat A, Berzofsky C, Budenz C, Moscatello A, Geliebter J, Tiwari RK. Abstract 2762: Identification of novel immunotherapeutic targets in anaplastic thyroid cancer Cancer Research. 78: 2762-2762. DOI: 10.1158/1538-7445.Am2018-2762 |
0.497 |
|
| 2018 |
O'Connell TJ, Gupta A, Jones M, Lando T, Jourdy D, Shin E, Moscatello A, Tiwari R, Geliebter J. Abstract 2737: Does androgen attenuation of PD-L1 expression in thyroid cancer modulate disease incidence Cancer Research. 78: 2737-2737. DOI: 10.1158/1538-7445.Am2018-2737 |
0.407 |
|
| 2018 |
Dadafarin S, Gupta A, Dermigny K, Jones M, O'Connell T, Rasamny J, Suslina N, Iacob I, Schwarcz M, Kamat A, Budenz C, Berzofsky C, Jourdy D, Lando T, Schantz S, ... ... Geliebter J, et al. Abstract 2469: Coding and non-coding RNA in papillary thyroid cancer - markers for disease progression Cancer Research. 78: 2469-2469. DOI: 10.1158/1538-7445.Am2018-2469 |
0.481 |
|
| 2017 |
Benedetti I, De Marzo AM, Geliebter J, Reyes N. CXXC5 expression in prostate cancer: implications for cancer progression. International Journal of Experimental Pathology. 98: 234-243. PMID 29027288 DOI: 10.1111/Iep.12241 |
0.503 |
|
| 2017 |
Rebollo J, Geliebter J, Reyes N. ESM-1 siRNA Knockdown Decreased Migration and Expression of CXCL3 in Prostate Cancer Cells. International Journal of Biomedical Science : Ijbs. 13: 35-42. PMID 28533735 |
0.348 |
|
| 2017 |
Chakraborty S, Maniyar RR, Tuli NY, Rahoma GB, Budenz C, Singh S, Geliebter J, Tiwari R. Abstract 5676: Functional pairing of immunomodulatory targets in anaplastic thyroid cancer Cancer Research. 77: 5676-5676. DOI: 10.1158/1538-7445.Am2017-5676 |
0.48 |
|
| 2017 |
O'Connell TJ, Jones M, Gupta A, Lando T, Jourdy D, Shin E, Moscatello A, Tiwari R, Geliebter J. Abstract 5575: Androgen receptor stimulation with 5α-dihydrotestosterone (DHT) decreases PD-L1 expression in androgen-responsive thyroid cancer cells Cancer Research. 77: 5575-5575. DOI: 10.1158/1538-7445.Am2017-5575 |
0.49 |
|
| 2017 |
Gupta A, O'Connell T, Jones M, Singh K, Schwarcz M, Rasamny J, Halicka D, Li J, Iacob C, Suslina N, Schantz S, Shin E, Darzynkiewicz Z, Tiwari R, Geliebter J. Abstract 4356: Methylation and expression of androgen receptor in Papillary Thyroid Cancer Cancer Research. 77: 4356-4356. DOI: 10.1158/1538-7445.Am2017-4356 |
0.46 |
|
| 2017 |
Tuli NY, Kamat A, Maniyar R, Rahoma GB, Chakraborty S, Singh S, Moscatello A, Geliebter J, Tiwari RK. Abstract 3973: Role of thyroid tumor microenvironment secretome in cancer initiation and progression Cancer Research. 77: 3973-3973. DOI: 10.1158/1538-7445.Am2017-3973 |
0.447 |
|
| 2017 |
Maniyar RR, Chakraborty S, Tuli N, Rahoma GB, Singh S, Geliebter J, Wallack M, Tiwari RK. Abstract 3656: Implication for checkpoint therapeutics: Expression of co-stimulatory and co-inhibitory molecules in melanoma cells Cancer Research. 77: 3656-3656. DOI: 10.1158/1538-7445.Am2017-3656 |
0.392 |
|
| 2017 |
Tuli NY, Berzofsky C, Maniyar R, Chakraborty S, Rahoma GB, Singh S, Geliebter J, Tiwari RK, Iacobas S, Iacobas DA. Abstract 3134: Hierarchical gene master regulators of papillary and anaplastic thyroid cancer phenotype Cancer Research. 77: 3134-3134. DOI: 10.1158/1538-7445.Am2017-3134 |
0.464 |
|
| 2017 |
Padron EIB, Marzo AD, Valle JBD, Geliebter J, Reyes N. Abstract 2414: Fibromodulin expression in human prostate cancer tissue: Implications for prostate cancer progression Cancer Research. 77: 2414-2414. DOI: 10.1158/1538-7445.Am2017-2414 |
0.471 |
|
| 2016 |
Tuli NY, Bednarczyk RB, Rahoma GMB, Moscatello A, Geliebter J, Tiwari RK. Abstract 4089: Thyroid tumor microenvironment: mutual interaction between cancer and inflammatory cells Cancer Research. 76: 4089-4089. DOI: 10.1158/1538-7445.Am2016-4089 |
0.502 |
|
| 2016 |
Rahoma GMB, Tuli NY, Bednarczyk RB, Maniyar RR, Mittelman A, Geliebter J, Tiwari R. Abstract 3263: Dietary supplement 3, 3’-diindolylmethane (DIM) as an antiangiogenic agent in breast cancer Cancer Research. 76: 3263-3263. DOI: 10.1158/1538-7445.Am2016-3263 |
0.394 |
|
| 2016 |
O’Connell T, Jones M, Gupta A, Moscatello A, Tiwari RK, Geliebter J. Abstract 3223: Androgen receptor stimulation decreases PD-L1 expression in androgen-responsive thyroid cancer cells Cancer Research. 76: 3223-3223. DOI: 10.1158/1538-7445.Am2016-3223 |
0.489 |
|
| 2016 |
Gupta A, Jones M, O’Connell T, Halicka D, Li J, Zhao H, Moscatello A, Darzynkiewicz Z, Tiwari R, Geliebter J. Abstract 2841: Continuous androgen receptor stimulation in thyroid cancer cells induces irreversible senescence Cancer Research. 76: 2841-2841. DOI: 10.1158/1538-7445.Am2016-2841 |
0.523 |
|
| 2016 |
Maniyar RR, Tuli N, Suriano R, Geliebter J, Wallack M, Tiwari RK. Abstract 2365: Checkpoint inhibitors and a multivalent melanoma vaccine as a novel combinatorial therapy Cancer Research. 76: 2365-2365. DOI: 10.1158/1538-7445.Am2016-2365 |
0.399 |
|
| 2015 |
Hanly EK, Tuli NY, Bednarczyk RB, Suriano R, Geliebter J, Moscatello AL, Darzynkiewicz Z, Tiwari RK. Hyperactive ERK and persistent mTOR signaling characterize vemurafenib resistance in papillary thyroid cancer cells. Oncotarget. PMID 26735176 DOI: 10.18632/Oncotarget.6779 |
0.436 |
|
| 2015 |
George AL, Suriano R, Rajoria S, Osso MC, Tuli N, Hanly E, Geliebter J, Arnold AN, Wallack M, Tiwari RK. PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells. Journal of Cancer. 6: 1320-1330. PMID 26640592 DOI: 10.7150/Jca.11126 |
0.383 |
|
| 2015 |
Choi D, Ramu S, Park E, Jung E, Yang S, Jung W, Choi I, Lee S, Kim KE, Seong YJ, Hong M, Daghlian GH, Kim D, Seo JI, Shin E, ... ... Geliebter J, et al. Aberrant activation of Notch signaling inhibits PROX1 activity to enhance the malignant behavior of thyroid cancer cells. Cancer Research. PMID 26609053 DOI: 10.1158/0008-5472.Can-15-1199 |
0.527 |
|
| 2015 |
Reyes N, Benedetti I, Bettin A, Rebollo J, Geliebter J. The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue. Cancer Biomarkers : Section a of Disease Markers. PMID 26600400 DOI: 10.3233/Cbm-150555 |
0.463 |
|
| 2015 |
Hanly EK, Bednarczyk RB, Tuli NY, Moscatello AL, Halicka HD, Li J, Geliebter J, Darzynkiewicz Z, Tiwari RK. mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib. Oncotarget. 6: 39702-13. PMID 26284586 DOI: 10.18632/Oncotarget.4052 |
0.477 |
|
| 2015 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack M. Abstract A30: Small molecule kinase inhibitor mediated modulation of immunotherapy in melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A30 |
0.396 |
|
| 2015 |
Hanly EK, Tuli NY, Bednarczyk RB, Moscatello AL, Darzynkiewicz Z, Geliebter J, Tiwari RK. Abstract 734: Synergistic antitumor effect of vemurafenib and metformin in thyroid cancer Cancer Research. 75: 734-734. DOI: 10.1158/1538-7445.Am2015-734 |
0.487 |
|
| 2015 |
Jones ME, O'Connell T, Gupta A, Zhao H, Iacob C, Moscatello A, Shin E, Darzynkiewicz Z, Tiwari RK, Geliebter J. Abstract 708: Androgen receptor activation inhibits papillary thyroid carcinoma cell cycle progression Cancer Research. 75: 708-708. DOI: 10.1158/1538-7445.Am2015-708 |
0.531 |
|
| 2015 |
Gupta A, Jones M, Moscatello A, Shin E, Tiwari RK, Geliebter J. Abstract 3926: RhoB expression is upregulated by androgen in thyroid cancer cells Cancer Research. 75: 3926-3926. DOI: 10.1158/1538-7445.Am2015-3926 |
0.544 |
|
| 2015 |
Singh K, Jones M, Moscatello A, Shin E, Tiwari R, Geliebter J. Abstract 1288: Does an increased underlying immune/inflammatory response in healthy females put them at a higher risk for thyroid cancer Immunology. 75: 1288-1288. DOI: 10.1158/1538-7445.Am2015-1288 |
0.398 |
|
| 2014 |
Hanly EK, Rajoria S, Darzynkiewicz Z, Zhao H, Suriano R, Tuli N, George AL, Bednarczyk R, Shin EJ, Geliebter J, Tiwari RK. Disruption of mutated BRAF signaling modulates thyroid cancer phenotype. Bmc Research Notes. 7: 187. PMID 24673746 DOI: 10.1186/1756-0500-7-187 |
0.506 |
|
| 2014 |
Rajoria S, Hanly E, Nicolini A, George AL, Geliebter J, Shin EJ, Suriano R, Carpi A, Tiwari RK. Interlinking of hypoxia and estrogen in thyroid cancer progression. Current Medicinal Chemistry. 21: 1351-60. PMID 24304276 DOI: 10.2174/0929867321666131201142434 |
0.503 |
|
| 2014 |
Tiwari RK, Suriano R, Banerjee D, Konopa J, Geliebter J, Mittelman A. Capridine-β, a new class of chemotherapeutic agents for prostate cancer. Journal of Clinical Oncology. 32: e16062-e16062. DOI: 10.1200/Jco.2014.32.15_Suppl.E16062 |
0.41 |
|
| 2014 |
Suriano R, Tuli N, Geliebter J, Tiwari RK, Wallack MK. Abstract 641: Targeted inhibition of BRAF signaling in melanoma enhances the activity of a multivalent immunotherapeutic vaccine Cancer Research. 74: 641-641. DOI: 10.1158/1538-7445.Am2014-641 |
0.407 |
|
| 2014 |
Reyes N, Correa O, Bettin A, Tiwari RK, Geliebter J. Abstract 4882: Expression profiles of proinflammatory chemokines in prostate cancer cell supernatants Cancer Research. 74: 4882-4882. DOI: 10.1158/1538-7445.Am2014-4882 |
0.504 |
|
| 2014 |
Hanly EK, Tuli NY, Suriano R, Bednarczyk R, Darzynkiewicz Z, Moscatello AL, Shin EJ, Geliebter J, Tiwari RK. Abstract 3709: Resistance mechanisms to targeted molecular therapy in thyroid cancer Cancer Research. 74: 3709-3709. DOI: 10.1158/1538-7445.Am2014-3709 |
0.523 |
|
| 2014 |
MacEwan ME, O'Connell T, Zhao H, Iacob C, Suslina N, Moscatello A, Shin E, Tiwari R, Darzynkiewicz Z, Geliebter J. Abstract 2122: Androgen decreases proliferation of thyroid cancer cells Cancer Research. 74: 2122-2122. DOI: 10.1158/1538-7445.Am2014-2122 |
0.514 |
|
| 2014 |
Tuli NY, Cabin J, Suriano R, Bednarczyk R, Hanly E, Geliebter J, Shin E, Tiwari RK. Abstract 1107: Tumor microenvironment based modulation of thyroid cancer phenotype Cancer Research. 74: 1107-1107. DOI: 10.1158/1538-7445.Am2014-1107 |
0.486 |
|
| 2013 |
Suriano R, Rajoria S, L George A, Geliebter J, Wallack M, Tiwari RK. Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines. Journal of Cancer. 4: 371-82. PMID 23833682 DOI: 10.7150/Jca.6625 |
0.376 |
|
| 2013 |
Wong K, Patel NA, Geliebter J, Shin EJ. Differences in Thyroid Cancer Trends between New York and Surveillance, Epidemiology, and End Results Database Otolaryngology–Head and Neck Surgery. 149: P150-P150. DOI: 10.1177/0194599813496044A25 |
0.339 |
|
| 2013 |
Rajoria S, Hanly E, George A, Suriano R, Geliebter J, Saman M, Schantz S, Tiwari RK. Abstract 96: Estrogen modulates cellular and molecular markers of hypoxic tumor microenvironment in thyroid cancer. Cancer Research. 73: 96-96. DOI: 10.1158/1538-7445.Am2013-96 |
0.516 |
|
| 2013 |
MacEwan ME, Wong K, Swati I, Xie S, Rasul M, Ardacheva O, Buchsbaum J, Shin E, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Abstract 3559: FKBP5 is an androgen-responsive gene in thyroid cancer cells. Cancer Research. 73: 3559-3559. DOI: 10.1158/1538-7445.Am2013-3559 |
0.514 |
|
| 2013 |
Benedetti I, Correa O, Geliebter J, Tiwari R, Reyes N. Abstract 2870: Prostatic inflammation and proliferative inflammatory atrophy: Are there any associations with prostatic cancer. Cancer Research. 73: 2870-2870. DOI: 10.1158/1538-7445.Am2013-2870 |
0.424 |
|
| 2013 |
Suriano R, George AL, Rajoria S, Geliebter J, Tiwari RK, Wallack M. Abstract 2829: Patient-derived primary melanoma cells that differentially express melano-specific antigens as a model for vaccines. Cancer Research. 73: 2829-2829. DOI: 10.1158/1538-7445.Am2013-2829 |
0.392 |
|
| 2013 |
Reyes N, Bettin A, Rebollo J, Correa O, Geliebter J. Abstract 2691: Chemokine expression profile in prostate cancer cell lines: Association with metastatic potential. Cancer Research. 73: 2691-2691. DOI: 10.1158/1538-7445.Am2013-2691 |
0.457 |
|
| 2013 |
Hanly EK, Rajoria S, George AL, Suriano R, Geliebter J, Pantelides H, Shin EJ, Tiwari RK. Abstract 1048: Targeted BRAF therapy attenuates the promotional activity of estrogen in thyroid cancer. Cancer Research. 73: 1048-1048. DOI: 10.1158/1538-7445.Am2013-1048 |
0.509 |
|
| 2012 |
Rajoria S, Suriano R, George AL, Kamat A, Schantz SP, Geliebter J, Tiwari RK. Molecular target based combinational therapeutic approaches in thyroid cancer. Journal of Translational Medicine. 10: 81. PMID 22548798 DOI: 10.1186/1479-5876-10-81 |
0.495 |
|
| 2012 |
Rajoria S, Suriano R, George AL, Shanmugam A, Jussim C, Shin EJ, Moscatello AL, Geliebter J, Carpi A, Tiwari RK. Estrogen activity as a preventive and therapeutic target in thyroid cancer. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 66: 151-8. PMID 22285105 DOI: 10.1016/J.Biopha.2011.11.010 |
0.484 |
|
| 2012 |
Kummer NT, Nowicki TS, Azzi JP, Reyes I, Iacob C, Xie S, Swati I, Darzynkiewicz Z, Gotlinger KH, Suslina N, Schantz S, Tiwari RK, Geliebter J. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction. Journal of Cellular Biochemistry. 113: 1998-2008. PMID 22253131 DOI: 10.1002/Jcb.24069 |
0.711 |
|
| 2012 |
M. Wong K, Scott Nowicki T, Puccio C, Ahmed T, Tiwari R, Geliebter J, Moscatello A. Clinical Response with Sunitinib Therapy in the Treatment of Anaplastic Thyroid Cancer Journal of Cancer Therapy. 3: 132-136. DOI: 10.4236/Jct.2012.32018 |
0.373 |
|
| 2012 |
MacEwan M, Swati I, Xie S, Ardacheva O, Iacob C, Shin E, Moscatello A, Schantz S, Tiwari RK, Geliebter J. Abstract 3921: Androgens stimulate phosphorylation of ERK and AKT in thyroid cancer cells Cancer Research. 72: 3921-3921. DOI: 10.1158/1538-7445.Am2012-3921 |
0.463 |
|
| 2012 |
Suriano R, Rajoria S, George A, Jussim C, Shanmugam A, Geliebter J, Tiwari RK, Wallack MK. Abstract 1569: Multivalent melanoma vaccine using primary human melanoma cells and a vaccinia virus based antigen retrieval system Cancer Research. 72: 1569-1569. DOI: 10.1158/1538-7445.Am2012-1569 |
0.388 |
|
| 2012 |
Rajoria S, George A, Suriano R, Shin EJ, Geliebter J, Tiwari RK. Abstract 1520: Estrogen modulates angiogenic factors of thyroid tumor microenvironment Cancer Research. 72: 1520-1520. DOI: 10.1158/1538-7445.Am2012-1520 |
0.514 |
|
| 2011 |
Darr EA, Patel AD, Yu G, Komorowski Z, McCormick S, Tiwari R, Schantz SP, Geliebter J. Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease. Archives of Otolaryngology--Head & Neck Surgery. 137: 1161-5. PMID 22106244 DOI: 10.1001/Archoto.2011.186 |
0.429 |
|
| 2011 |
Nowicki TS, Moscatello AL, Shin E, Schantz S, Tiwari RK, Geliebter J. The urokinase plasminogen activator system in metastatic papillary thyroid carcinoma: a potential therapeutic target. The Journal of Clinical Endocrinology and Metabolism. 96: 3062-4. PMID 21832115 DOI: 10.1210/Jc.2011-1123 |
0.732 |
|
| 2011 |
Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. Plos One. 6: e15879. PMID 21267453 DOI: 10.1371/Journal.Pone.0015879 |
0.521 |
|
| 2011 |
Rajoria S, Suriano R, Parmar PS, Wilson YL, Megwalu U, Moscatello A, Bradlow HL, Sepkovic DW, Geliebter J, Schantz SP, Tiwari RK. 3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study. Thyroid : Official Journal of the American Thyroid Association. 21: 299-304. PMID 21254914 DOI: 10.1089/Thy.2010.0245 |
0.454 |
|
| 2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, Tiwari RK, Geliebter J. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle (Georgetown, Tex.). 10: 100-7. PMID 21191179 DOI: 10.4161/Cc.10.1.14362 |
0.743 |
|
| 2011 |
Rajoria S, Suriano R, Wilson YL, Schantz SP, Moscatello A, Geliebter J, Tiwari RK. 3,3'-diindolylmethane inhibits migration and invasion of human cancer cells through combined suppression of ERK and AKT pathways. Oncology Reports. 25: 491-7. PMID 21152869 DOI: 10.3892/Or.2010.1076 |
0.463 |
|
| 2011 |
Reyes N, Bettin A, Causil C, Reyes I, Geliebter J. Abstract A24: Evaluation and validation of biomarkers for prostate cancer early diagnosis Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A24 |
0.445 |
|
| 2011 |
Reyes N, Bettin A, Rebollo J, Tiwari R, Geliebter J. Abstract 5185: Evaluation of biomarker candidate genes for prostate cancer metastasis Cancer Research. 71: 5185-5185. DOI: 10.1158/1538-7445.Am2011-5185 |
0.439 |
|
| 2011 |
MacEwan M, Mehta V, Darr EA, Xie S, Nowicki TS, Iacob C, Suslina N, Reyes I, Schantz S, Shin E, Tiwari R, Geliebter J. Abstract 1502: Increased expression of KLK7 and KLK10 in papillary thyroid cancer Cancer Research. 71: 1502-1502. DOI: 10.1158/1538-7445.Am2011-1502 |
0.769 |
|
| 2011 |
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Schantz S, Shin E, Tiwari RK, Geliebter J. Abstract 1406: Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling, and induces senescence in papillary thyroid carcinoma cells Cancer Research. 71: 1406-1406. DOI: 10.1158/1538-7445.Am2011-1406 |
0.748 |
|
| 2011 |
Rajoria S, George A, Shanmugam A, Kamat A, Schantz SP, Geliebter J, Suriano R, Tiwari RK. Abstract 1320: Estrogen as a modulator of thyroid proliferative disease: Implications for disease etiology and therapy Cancer Research. 71: 1320-1320. DOI: 10.1158/1538-7445.Am2011-1320 |
0.314 |
|
| 2011 |
Darr EA, Nowicki TS, Kummer N, MacEwan M, Dunbar J, Suslina N, Iacob C, Shin E, Schantz S, Tiwari R, Geliebter J. Abstract 1063: BRAFV600Estatus predicts higher uPA levels in papillary thyroid cancer Cancer Research. 71: 1063-1063. DOI: 10.1158/1538-7445.Am2011-1063 |
0.742 |
|
| 2011 |
Ashlie Darr E, Nowicki TS, MacEwan ME, Dunbar J, Iacob C, Geliebter J. BRAFV600E is associated with increased uPA levels in papillary thyroid cancer Laryngoscope. 121. DOI: 10.1002/Lary.22229 |
0.72 |
|
| 2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Schaefer S, Schantz S, Shin E, Moscatello AL, Tiwari RK, Geliebter J. Inhibition of uPAR and uPA reduces invasion in papillary thyroid carcinoma cells. The Laryngoscope. 120: 1383-90. PMID 20578104 DOI: 10.1002/Lary.20915 |
0.735 |
|
| 2010 |
Hofkamp LE, Bradley S, Geliebter J, Timms BG. Atypical fetal prostate development is associated with ipsilateral hypoplasia of the wolffian ducts in the ACI rat. Anatomical Record (Hoboken, N.J. : 2007). 293: 747-53. PMID 20091891 DOI: 10.1002/Ar.21073 |
0.37 |
|
| 2010 |
Rajoria S, Suriano R, Shanmugam A, Wilson YL, Schantz SP, Geliebter J, Tiwari RK. Metastatic phenotype is regulated by estrogen in thyroid cells. Thyroid : Official Journal of the American Thyroid Association. 20: 33-41. PMID 20067378 DOI: 10.1089/Thy.2009.0296 |
0.498 |
|
| 2010 |
Rajoria S, George A, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK, Suriano R. Abstract 5683: The dietary anti-estrogenic agent 3,3′-diindolylmethane inhibits metastatic propensity in thyroid cancer cells Cancer Research. 70: 5683-5683. DOI: 10.1158/1538-7445.Am10-5683 |
0.542 |
|
| 2010 |
Kummer NT, Bedwell J, Nowiki TS, Schantz S, Shin E, Schaefer S, Tiwari RK, Geliebter J. Abstract 529: Matrix metalloproteinase expression and secretion in papillary thyroid carcinoma Cancer Research. 70: 529-529. DOI: 10.1158/1538-7445.Am10-529 |
0.442 |
|
| 2010 |
Nowicki TS, Kummer NT, Iacob C, Suslina N, Moscatello A, Schantz S, Schaefer S, Shin E, Tiwari RK, Geliebter J. Abstract 520: Inhibition of uPAR and uPA reduces invasion and degradative potential in papillary thyroid carcinoma cells Cancer Research. 70: 520-520. DOI: 10.1158/1538-7445.Am10-520 |
0.759 |
|
| 2010 |
Rajoria S, Suriano R, Shanmugam A, Megwalu U, Schantz SP, Geliebter J, Tiwari RK. Abstract 420: Metastatic and neo-vasculature determinants as prognostic markers of thyroid cancer Cancer Research. 70: 420-420. DOI: 10.1158/1538-7445.Am10-420 |
0.512 |
|
| 2010 |
Mehta V, Cooke SL, Yu G, Nowicki TS, Geliebter J, Tran T, Persky MS. Increased estrogen and the risk of papillary thyroid cancer Laryngoscope. 120: S16. DOI: 10.1002/Lary.21194 |
0.724 |
|
| 2007 |
Reyes I, Tiwari R, Geliebter J, Reyes N. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines. BioméDica : Revista Del Instituto Nacional De Salud. 27: 190-203. PMID 17713630 |
0.388 |
|
| 2007 |
Reyes I, Tiwari R, Geliebter J, Reyes N. Análisis de micromatrices de ADN revela genes asociados a metástasis en líneas celulares de cáncer de próstata de rata BioméDica. 27: 192. DOI: 10.7705/Biomedica.V27I2.215 |
0.478 |
|
| 2006 |
Mashkevich G, Schantz SP, Geliebter J. 11:00 AM: Activation of Growth Factor Receptors in Thyroid Carcinoma Otolaryngology–Head and Neck Surgery. 135: P92-P93. DOI: 10.1016/J.Otohns.2006.06.1241 |
0.348 |
|
| 2005 |
Tadi K, Chang Y, Ashok BT, Chen Y, Moscatello A, Schaefer SD, Schantz SP, Policastro AJ, Geliebter J, Tiwari RK. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochemical and Biophysical Research Communications. 337: 1019-25. PMID 16219298 DOI: 10.1016/J.Bbrc.2005.09.143 |
0.404 |
|
| 2005 |
Reyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J. Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. The Prostate. 63: 169-86. PMID 15486989 DOI: 10.1002/Pros.20164 |
0.45 |
|
| 2004 |
Reyes N, Reyes I, Tiwari R, Geliebter J. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Letters. 209: 25-35. PMID 15145518 DOI: 10.1016/J.Canlet.2003.12.010 |
0.345 |
|
| 2003 |
Kanduc D, Capuano F, Capurso SA, Geliebter J, Guercia D, Lucchese A, Mittelman A, Simone SM, Sinha AA, Tiwari R, Farber E. Cancer prevention and therapy: strategies and problems. Journal of Experimental Therapeutics & Oncology. 3: 108-14. PMID 14641817 DOI: 10.1046/J.1359-4117.2003.01086.X |
0.372 |
|
| 2001 |
Geliebter J, Mittelman A, Tiwari RK. PC-SPES and prostate cancer Journal of Nutrition. 131. PMID 11208956 DOI: 10.1093/Jn/131.1.164S |
0.442 |
|
| 2001 |
Zeoli CD, Maitland M, Rose H, Bloom B, Mittelman A, Geliebter J. Expression of prostate specific molecules in Bacille Calmette-Guerin: An immunotherapeutic approach to prostate cancer Prostate Journal. 3: 92-97. DOI: 10.1046/J.1525-1411.2001.32002.X |
0.64 |
|
| 1999 |
Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. International Journal of Oncology. 14: 713-9. PMID 10087319 DOI: 10.3892/Ijo.14.4.713 |
0.416 |
|
| 1999 |
Geliebter J, Tiwari R, Wu JM. PC-SPES in prostate cancer The New England Journal of Medicine. 340: 567-568. PMID 10026051 |
0.336 |
|
| 1999 |
Small EJ, Geliebter J, Tiwari R, Wu JM, DiPaola RS, Hait WN, Gallo MA. PC-SPES in prostate cancer [2] (multiple letters) New England Journal of Medicine. 340: 566-568. PMID 10026050 DOI: 10.1056/NEJM199902183400714 |
0.334 |
|
| 1996 |
Tsai H, Werber J, Davia MO, Edelman M, Tanaka KE, Melman A, Christ GJ, Geliebter J. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochemical and Biophysical Research Communications. 227: 64-9. PMID 8858104 DOI: 10.1006/bbrc.1996.1468 |
0.384 |
|
| Show low-probability matches. |